PALO ALTO, Calif., June 27, 2022 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure hepatitis delta virus (HDV) and other serious diseases, today announced data...
News Ticker
- [ June 10, 2023 ] Senior Manager, Field Market Access Operations Analytics (REMOTE) – Jazz Pharmaceuticals – Palo Alto, CA San Francisco Biotech Jobs
- [ June 10, 2023 ] Senior Research Associate – Bruker – San Jose, CA San Francisco Biotech Jobs
- [ June 10, 2023 ] Sr. Associate Scientist, Upstream Development for Protein Development and Manufacturing – Vaxcyte – San Carlos, CA San Francisco Biotech Jobs
- [ June 10, 2023 ] Research Associate/Senior Research Associate – Vector Engineering – Cargo Therapeutics – San Mateo, CA San Francisco Biotech Jobs
- [ June 10, 2023 ] Sr. Scientist, Upstream Development for Protein Development and Manufacturing – Vaxcyte – San Carlos, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
